EE+ POEM Archive
Alirocumab has minimal net benefit for patients with hyperlipidemia (ODYSSEY LONG TERM)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Alirocumab Has Minimal Net Benefit for Patients With Hyperlipidemia (ODYSSEY LONG TERM)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/428328/all/Alirocumab_has_minimal_net_benefit_for_patients_with_hyperlipidemia__ODYSSEY_LONG_TERM_.
Alirocumab has minimal net benefit for patients with hyperlipidemia (ODYSSEY LONG TERM). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428328/all/Alirocumab_has_minimal_net_benefit_for_patients_with_hyperlipidemia__ODYSSEY_LONG_TERM_. Accessed September 9, 2024.
Alirocumab has minimal net benefit for patients with hyperlipidemia (ODYSSEY LONG TERM). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428328/all/Alirocumab_has_minimal_net_benefit_for_patients_with_hyperlipidemia__ODYSSEY_LONG_TERM_
Alirocumab Has Minimal Net Benefit for Patients With Hyperlipidemia (ODYSSEY LONG TERM) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 September 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428328/all/Alirocumab_has_minimal_net_benefit_for_patients_with_hyperlipidemia__ODYSSEY_LONG_TERM_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Alirocumab has minimal net benefit for patients with hyperlipidemia (ODYSSEY LONG TERM)
ID - 428328
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428328/all/Alirocumab_has_minimal_net_benefit_for_patients_with_hyperlipidemia__ODYSSEY_LONG_TERM_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
